Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Sell
15
ENTA Quote, Financials, Valuation and Earnings
Last price:
$5.12
Seasonality move
:
-2.51%
Day range:
$4.73 - $5.11
52-week range:
$4.09 - $17.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.57x
P/B ratio:
0.94x
Volume:
358.2K
Avg. volume:
265.9K
1-year change:
-67.9%
Market cap:
$105.2M
Revenue:
$67.6M
EPS (TTM):
-$4.95
Enanta Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
ENTA
Enanta Pharmaceuticals
|
05/08/2024 | 10-Q | 10-Q filing on 05/08/2024 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2024 | 10-Q | 10-Q filing on 02/08/2024 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2023 | 10-Q | 10-Q filing on 02/08/2023 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/10/2022 | 10-Q | 10-Q filing on 02/10/2022 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2021 | 10-Q | 10-Q filing on 02/09/2021 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/25/2020 | 10-K | 10-K filing on 11/25/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/10/2020 | 10-Q | 10-Q filing on 02/10/2020 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/27/2019 | 10-K | 10-K filing on 11/27/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/08/2019 | 10-Q | 10-Q filing on 02/08/2019 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
11/29/2018 | 10-K | 10-K filing on 11/29/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2018 | 10-Q | 10-Q filing on 08/09/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2018 | 10-Q | 10-Q filing on 02/09/2018 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/11/2017 | 10-K | 10-K filing on 12/11/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2017 | 10-Q | 10-Q filing on 08/09/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2017 | 10-Q | 10-Q filing on 05/10/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2017 | 10-Q | 10-Q filing on 02/09/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
01/06/2017 | 10-K | 10-K filing on 01/06/2017 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/09/2016 | 10-K | 10-K filing on 12/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
02/09/2016 | 10-Q | 10-Q filing on 02/09/2016 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
12/11/2015 | 10-K | 10-K filing on 12/11/2015 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
ENTA
Enanta Pharmaceuticals
|
05/08/2015 | 10-Q | 10-Q filing on 05/08/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
How High Will MSTY Go By 2030?
YieldMax’s MSTR Option Income Strategy ETF (MSTY) is a high-yield…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 36x
Alerts
Buy
91
TORXF alert for Apr 17
Torex Gold Resources [TORXF] is down 2.15% over the past day.
Sell
25
BULZ alert for Apr 17
MicroSectors Solactive FANG & Innov 3X Levd ETN [BULZ] is down 1.92% over the past day.
Sell
44
VIST alert for Apr 17
Vista Energy SAB de CV [VIST] is up 6.93% over the past day.
